BPC-157 Clinical Trials: Results & How to Enroll
Complete guide to BPC-157 clinical trial history, published results, and current research status.
Clinical Trial History
Multiple rodent studies show significantly accelerated tendon-to-bone healing, reduced inflammation, and improved functional outcomes with BPC-157 vs controls.
Limited human data exists. Topical rectal application showed some benefit in a small Crohn's disease trial. No completed Phase 3 trials.
Frequently Asked Questions
What clinical trials have studied BPC-157?
BPC-157 has been studied in multiple clinical trials. The key findings are documented in the clinical research section of this guide. Refer to ClinicalTrials.gov for complete trial records and enrollment information.
Is BPC-157 still in clinical trials?
No FDA approval. Research use only.. For current trial status, search ClinicalTrials.gov using the drug name "BPC-157".
References & Sources
- [1]Sikirić PC, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016;14(8):857–865.
- [2]Chang CH, et al. The Promoting Effect of Pentadecapeptide BPC 157 on Tendon Healing Involves Tendon Outgrowth, Cell Survival, and Cell Migration. J Appl Physiol. 2011;110(3):774–780.
- [3]ClinicalTrials.gov — BPC 157 registered trials
- [4]Note: Most BPC-157 evidence comes from animal studies. No large-scale human RCTs have been published to date.
Exploring Retatrutide Access?
See how patients are accessing retatrutide through physician-supervised telehealth and compounding pharmacies.
Not FDA approved. Access requires physician oversight.
Affiliate links — we may earn a commission at no cost to you.